Abstract
Determine whether clinical estimates of insulin secretion derived from oral glucose tolerance test (OGTT) might improve cystic fibrosis-related diabetes (CFRD) risk prediction.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
